CA Stock MarketDetailed Quotes

GUD Knight Therapeutics Inc

Watchlist
  • 6.000
  • -0.040-0.66%
15min DelayMarket Closed Mar 27 16:00 ET
600.29MMarket Cap150.00P/E (TTM)

Knight Therapeutics Inc Key Stats

Knight Therapeutics Inc Q4 2024 Earnings Date

Currency:CADMar 20, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
87.62M
96.86M
+9.24M
Beat Est.
+18.09%
+30.55%
+10.55%
EPS
0.01
0.10
+0.09
Beat Est.
+106.09%
+143.48%
+614.29%

Knight Therapeutics Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 97.531M--
--2025/Q1-- / 87.672M--
Mar 20, 20252024/Q496.864M / 87.621M--
Nov 7, 20242024/Q392.263M / 89.426M--
Aug 8, 20242024/Q295.573M / 87.667M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 97.531M--
--2025/Q1-- / 87.672M--
Mar 20, 20252024/Q496.864M / 87.621M--
Nov 7, 20242024/Q392.263M / 89.426M--
Aug 8, 20242024/Q295.573M / 87.667M--

Unlock Free Earnings Estimates

Knight Therapeutics Inc Earnings Reports

Read more

Market Insights
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.